Global Protein Engineering Market is Estimated to Grow from USD 2.2 Billion in 2019 to USD 3.9 Billion by 2024 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Protein Engineering Market by Technology (Rational Design, Irrational Design), Product & Service (Instrument, Consumables), Protein Type (Monoclonal Antibodies, Insulin), End User (Academics Institutes, Biopharmaceuticals, CROs) – Global Forecast to 2024” report has been added to ResearchAndMarkets.com’s offering.

The increasing focus on protein-based drug development by pharmaceutical and biotechnology firms is expected to drive the overall growth of the protein engineering market

The major factors driving the growth of this market include the increasing investments in synthetic biology and the growing focus on protein-based drug development by pharmaceutical and biotechnology companies.

Instruments segment to account for the largest share of the protein engineering market, by product & service, in 2019

Based on product & service, the protein engineering market is segmented into instruments, consumables, and software & services. Instruments formed the largest product segment in this market in 2019 due to technological advancements in mass spectrometry and X-ray crystallography systems and their ability to integrate with other technologies.

Monoclonal antibodies segment to grow at the highest CAGR in the protein engineering market, by protein type, in 2019

Based on protein type, the protein engineering market is segmented into monoclonal antibodies, insulin, erythropoietin, interferons, vaccines, colony-stimulating factors, growth hormones, coagulation factors, and other proteins. The monoclonal antibodies segment is estimated to grow at the highest CAGR in this market owing to the increasing demand for monoclonal antibodies for the treatment of cancer, neurological diseases, and infectious diseases.

Rational protein design segment to grow at the highest CAGR in the protein engineering market, by technology, in 2019

Based on technology, the protein engineering market is segmented into rational and irrational protein design. The rational protein design segment is estimated to grow at the highest CAGR in this market during the forecast period majorly due to the growing use and continuous upgrades of bioinformatics platforms and software for protein analysis.

North America is estimated to be the largest regional market for protein engineering products and services during the forecast period

In 2019, North America accounted for the largest share of the global protein engineering market, majorly due to the presence of well-established CROs, rising R&D expenditure, and the availability of the latest techniques and instruments for drug discovery research in the region. Also, the increased adoption of biologic drugs such as monoclonal antibodies, erythropoietin, and interferons for the treatment of chronic diseases is the major factor driving the growth of the North American market.

In-depth interviews were conducted with CEOs, marketing directors, other innovation and technology directors, and executives from various key organizations operating in the protein engineering market.

Key Benefits of Buying the Report:

This report will help market leaders as well as new entrants in the market by providing information on the closest approximations of the revenue numbers for the overall protein engineering market and its subsegments. It will also help stakeholders to understand the competitive landscape, gain more insights to better position their businesses, and plan suitable go-to-market strategies.

Key Topics Covered:

1 Introduction

1.1 Objectives of the Study

1.2 Market Definition

1.3 Markets Covered

1.4 Years Considered for the Study

1.5 Currency

1.6 Limitations

1.7 Stakeholders

2 Research Methodology

2.1 Research Data

2.1.1 Secondary Data

2.1.2 Primary Data

2.2 Market Size Estimation

2.3 Data Triangulation

2.3.1 Assumptions for the Study

2.3.2 Limitations

3 Executive Summary

4 Premium Insights

4.1 Market Overview

4.2 Asia Pacific: Market, By Product (2018)

4.3 Market, By End User (2018)

4.4 Market, By Region (2018)

5 Market Overview

5.1 Introduction

5.2 Market Dynamics

5.2.1 Drivers

5.2.2 Restraints

5.2.3 Opportunities

6 Protein Engineering Market, By Product & Service

6.1 Introduction

6.2 Instruments

6.3 Consumables

6.4 Software & Services

7 Protein Engineering Market, By Protein Type

7.1 Introduction

7.2 Monoclonal Antibodies

7.3 Insulin

7.4 Erythropoietins

7.5 Interferons

7.6 Vaccines

7.7 Colony-Stimulating Factors

7.8 Growth Hormones

7.9 Coagulation Factors

7.10 Other Proteins

8 Protein Engineering Market, By Technology

8.1 Introduction

8.2 Rational Protein Design

8.3 Irrational Protein Design/Directed Evolution

9 Protein Engineering Market, By End User

9.1 Introduction

9.2 Biopharmaceutical Companies

9.3 Contract Research Organizations

9.4 Academic Research Institutes

10 Protein Engineering Market, By Region

10.1 Introduction

10.2 North America

10.3 Europe

10.4 Asia Pacific

10.5 Rest of the World

11 Competitive Landscape

11.1 Introduction

11.2 Market Rank Analysis, 2018

11.3 Competitive Leadership Mapping (2019)

11.4 Competitive Scenario

12 Company Profiles

12.1 Thermo Fisher Scientific, Inc.

12.2 Danaher Corporation

12.3 Agilent Technologies, Inc.

12.4 Bio-Rad Laboratories, Inc.

12.5 Bruker Corporation

12.6 Genscript Biotech Corporation

12.7 Codexis, Inc.

12.8 Waters Corporation

12.9 New England Biolabs, Inc.

12.10 Merck KGaA

12.11 Perkinelmer, Inc.

12.12 GE Healthcare

12.13 Creative Biolabs

12.14 Enantis S.R.O.

12.15 Promega Corporation

12.16 Abzena, Ltd.

12.17 Proteogenix

12.18 Innovagen AB

12.19 Phynexus, Inc. (A Part of Biotage)

12.20 Takara Bio, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/lenqlk

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900